Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Online study and academic help platform Chegg (NYSE:CHGG) announced better-than-expected revenue in Q3 CY2025, but sales fell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback